PinnyPeptide

FTPP-Adipotide vs Semaglutide

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

FTPP-Adipotide

Weight Management

Vasculature-targeting peptide that selectively destroys adipose blood vessels.

Peptide B

Semaglutide

Weight Management

GLP-1 receptor agonist revolutionizing the treatment of obesity and type 2 diabetes.

Typical vial

5 mg

Typical dose

Per kg dosing (research-only) mcg

Half-life

~hours

FDA status

Not FDA approved.

Typical vial

3 mg

Typical dose

250-2400 mcg

Half-life

~7 days (168 hours)

FDA status

FDA approved. Ozempic (2017) for type 2 diabetes, Rybelsus (…

FTPP-Adipotide effects

  • Selective destruction of white adipose tissue vasculature
  • Rapid weight and fat loss in primate models
  • Improved insulin sensitivity
  • Brown adipose tissue largely spared
  • Mechanism distinct from lipolytic / appetite-suppressing peptides

Semaglutide effects

  • Significant and sustained weight loss (15-17% body weight in trials)
  • Improved glycemic control and reduced HbA1c
  • Reduced appetite and food cravings through central satiety signaling
  • Cardiovascular risk reduction (20% MACE reduction in SELECT trial)
  • Slowed gastric emptying for prolonged satiety
  • Improved insulin sensitivity and beta-cell function

FTPP-Adipotide side effects

  • Renal toxicity (prohibitin expressed in kidney vasculature) — significant safety concern
  • Possible damage to other prohibitin-expressing vascular beds
  • Injection-site reactions
  • Limited human safety data
  • Acute inflammatory response from adipose vascular death

Semaglutide side effects

  • Nausea (most common, especially during dose titration)
  • Vomiting and diarrhea
  • Constipation
  • Abdominal pain and dyspepsia
  • Pancreatitis (rare but serious)

FTPP-Adipotide dosing ranges

Animal research (rhesus monkey model)

0.43 mg/kg · Daily SubQ × 28 days · Per published protocol

Human self-experimentation

Not recommended · — · —

Semaglutide dosing ranges

Type 2 diabetes (Ozempic)

250-1000 mcg · Once weekly (SubQ) · Ongoing as prescribed

Weight management (Wegovy)

2400 mcg · Once weekly (SubQ, after 16-week titration) · Ongoing as prescribed

Full FTPP-Adipotide guide → Full Semaglutide guide →

FTPP-Adipotide vs Semaglutide — common questions

What is the difference between FTPP-Adipotide and Semaglutide?

FTPP-Adipotide: Vasculature-targeting peptide that selectively destroys adipose blood vessels. Typical dose Per kg dosing (research-only) mcg. Semaglutide: GLP-1 receptor agonist revolutionizing the treatment of obesity and type 2 diabetes. Typical dose 250-2400 mcg. Both fall under the Weight Management category.

Can you stack FTPP-Adipotide and Semaglutide?

Stacking FTPP-Adipotide with Semaglutide is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, FTPP-Adipotide or Semaglutide?

FTPP-Adipotide is typically dosed: Daily SubQ × 28 days for Animal research (rhesus monkey model); — for Human self-experimentation. Semaglutide is typically dosed: Once weekly (SubQ) for Type 2 diabetes (Ozempic); Once weekly (SubQ, after 16-week titration) for Weight management (Wegovy).

Are FTPP-Adipotide and Semaglutide FDA approved?

FTPP-Adipotide: Not FDA approved. Semaglutide: FDA approved. Ozempic (2017) for type 2 diabetes, Rybelsus (2019) oral for diabetes, Wegovy (2021) for chronic weight management.

Related peptide comparisons

aod-9604 vs ftpp-adipotideftpp-adipotide vs hgh-fragment-176-191ftpp-adipotide vs retatrutideftpp-adipotide vs survodutideftpp-adipotide vs tirzepatideaod-9604 vs semaglutide

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free